Home > Insider Trading > Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc. (ARWR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50
Next >>

Is Arrowhead Pharmaceuticals Inc (ARWR)’s Recently Published U.S. Patent Application A Blockbuster?

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) business model of going after extrahepatic targets and establishing first mover advantage has the potential to be amplified by gaining patent protection for...

Keep Reading →

August 28th, 2019 - News Stock Analysis

Hedge Funds Have Never Been This Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)

A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as a result.

Keep Reading →

June 24th, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Arrowhead Pharmaceuticals, Inc. (ARWR)

Is Arrowhead Pharmaceuticals, Inc.

Keep Reading →

May 2nd, 2019 - Hedge Funds News

Arrowhead Pharmaceuticals, Inc. (ARWR): Hedge Funds Are Snapping Up

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly...

Keep Reading →

December 21st, 2018 - Hedge Funds News

Hedge Fund and Insider Trading News: Marc Lasry, Elliott Management, Third Point LLC, StealthGas Inc. (GASS), Pivotal Software Inc (PVTL), and More

Who knows what’s moving markets? Marc Lasry says he knows. It’s politics, and concern the Democrats will triumph in next week’s midterms.

Keep Reading →

October 31st, 2018 - Hedge Funds Insider Trading

Here is What Hedge Funds Think About Arrowhead Pharmaceuticals Inc (ARWR)

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million...

Keep Reading →

December 12th, 2016 - Hedge Funds News

Arrowhead Pharmaceuticals Inc (ARWR): Any Good Hearted Billionaires Out There (Willing To Pick Up Where Arrowhead Left Off)?

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) just shocked markets with the announcement that it would be discontinuing its lead development programs.

Keep Reading →

November 30th, 2016 - News Stock Analysis

Today's Movers And Shakers In Biotech: Arrowhead Pharmaceuticals Inc (ARWR) And Kite Pharma Inc (KITE)

One thing in particular pushed the sector higher today, and so before we get going on the specific entities, it’s worth addressing. Specifically, he election of Donald Trump to the White House.

Keep Reading →

November 11th, 2016 - Market Movers News Stock Analysis

The Chairmen of 4 Companies Unload Shares, Plus Insider Buying at Lions Gate (LGF)

The markets are in the green this morning, buoyed by existing home sales rising by 3.2% in September. On the other hand, weekly jobless claims in the U.S.

Keep Reading →

October 20th, 2016 - Insider Trading News